A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.
Researchers at Tel Aviv University (TAU) discovered a new factor in the pathology of Parkinson's disease, which in the future ...
Nearly one million people in the U.S. are living with Parkinson's Disease. Playhouse Square is rolling out a new program to ...
Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...
A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has ...
Mary Andre Burke Hutson, 73, of Signal Mountain, passed away peacefully on Saturday, November 9, 2024, after a long battle ...
John Rzeznik, Brian Fallon, Pete Steinkopf, Dramarama, Willie Nile, Joe Grushecky and the Houserockers and more set for Bob's Birthday Bash.
Nir Giladi from TAU’s Faculty of Medical and Health Sciences and the Tel Aviv Sourasky Medical Center, as well as other researchers from TAU and the University of Haifa. The study was backed by the ...
GSK Plc agreed on a partnership deal worth as much as $650 million with US biotech Vesalius Therapeutics to help advance drug ...
GSK is paying $80 million to ink a multi-target neurodegenerative pact with Flagship-founded Vesalius Therapeutics that ...
Healthcare Asia on MSN23h
7MM Parkinson’s disease pipeline focuses on disease-modifying agentsThere are a total of 93 products in Phase I-III development for PD treatment. The Parkinson’s disease (PD) therapeutic ...
Researchers at Tel Aviv University (TAU) discovered a new factor in the pathology of Parkinson's disease, which in the future ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback